Preoperative hemoglobin to albumin ratio predicts colorectal cancer outcomes

A study involving 4,018 colorectal cancer patients revealed that the hemoglobin to albumin ratio (HAR) serves as a significant prognostic factor. Patients with a high HAR demonstrated better overall survival (OS) and disease-free survival (DFS) compared to those with a low HAR, particularly in stage III CRC. HAR was identified as an independent risk factor, influencing overall complications and survival rates. These findings highlight the importance of preoperative assessments of hemoglobin and albumin levels in surgical decision-making.